acetylcysteine has been researched along with Epilepsy Progressive Myoclonic 2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dubey, D; Ganesh, S; Mittal, S; Yamakawa, K | 1 |
Ben-Menachem, E; Kyllerman, M; Marklund, S | 1 |
2 other study(ies) available for acetylcysteine and Epilepsy Progressive Myoclonic 2
Article | Year |
---|---|
Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment.
Topics: Acetylcysteine; Animals; Carrier Proteins; Cell Line; Cell Line, Tumor; Centrosome; Chlorocebus aethiops; COS Cells; Cysteine Proteinase Inhibitors; Endoplasmic Reticulum; Green Fluorescent Proteins; Humans; Immunoblotting; Immunohistochemistry; Inclusion Bodies; Lafora Disease; Leupeptins; Microscopy, Fluorescence; Proteasome Endopeptidase Complex; Protein Binding; Protein Tyrosine Phosphatases; Protein Tyrosine Phosphatases, Non-Receptor; Recombinant Fusion Proteins; Transfection; Tubulin; Ubiquitin; Ubiquitin-Protein Ligases | 2007 |
Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies.
Topics: Acetylcysteine; Adult; Epilepsies, Myoclonic; Erythrocytes; Female; Glutathione Peroxidase; Humans; Lafora Disease; Male; Reference Values; Superoxide Dismutase; Unverricht-Lundborg Syndrome | 2000 |